These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33116474)

  • 1. Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
    Lei YF; Lin HC; Lin HL; Uang YS; Cheng HW; Wang LH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2573-2581. PubMed ID: 33116474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between antihyperlipidemic agents and the risk of chronic periodontitis in patients with hyperlipidemia: A population-based retrospective cohort study in Taiwan.
    Wang AY; Lin GL; Keller JJ; Wang LH
    J Periodontol; 2024 May; 95(5):483-493. PubMed ID: 37793052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
    Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia and statins affect neurological outcome in lumbar spine injury.
    Chung WF; Liu SW; Chang PY; Lin FS; Chen LF; Wu JC; Chen YC; Liu L; Huang WC; Cheng H; Lo SS
    Int J Environ Res Public Health; 2015 Jan; 12(1):402-13. PubMed ID: 25568970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
    Chen CH; Lin HC; Lin HL; Keller JJ; Wang LH
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.
    Raymakers A; Sin DD; Sadatsafavi M; FitzGerald JM; Marra CA; Lynd LD
    Respir Res; 2020 May; 21(1):118. PubMed ID: 32429927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Nationwide Population-Based Cohort Study.
    Yang HY; Hu LY; Chen HJ; Chen RY; Hu CK; Shen CC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between statin use and dry eye disease in patients with hyperlipidemia: A population-based retrospective cohort study.
    Wang YW; Liu SD; Lin GL; Huang EJ; Keller JJ; Wang LH
    Clin Transl Sci; 2024 Oct; 17(10):e70039. PubMed ID: 39356083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
    Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY
    Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.
    Lin HW; Lin LF; Chen HC; Liou TH; Huang SW
    PLoS One; 2018; 13(9):e0203377. PubMed ID: 30188953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
    Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
    Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
    Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY
    Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between statin use and osteoporotic fracture in patients with chronic obstructive pulmonary disease: a population-based, matched case-control study.
    Chen HY; Su PY; Lin TK; Jong GP
    Lipids Health Dis; 2020 Nov; 19(1):232. PubMed ID: 33143674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.
    Liu JC; Hao WR; Hsu YP; Sung LC; Kao PF; Lin CF; Wu AT; Yuan KS; Wu SY
    Oncotarget; 2016 Oct; 7(40):65270-65283. PubMed ID: 27542242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Yu HH; Chen PC; Yang YH; Wang LC; Lee JH; Lin YT; Chiang BL
    Atherosclerosis; 2015 Nov; 243(1):11-8. PubMed ID: 26342937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.
    Sheng X; Murphy MJ; MacDonald TM; Schembri S; Simpson W; Winter J; Winter JH; Wei L
    Clin Ther; 2012 Feb; 34(2):374-84. PubMed ID: 22244052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.